Lyell Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $282K | Sell |
1,520
-95
| -6% | -$17.6K | 0.02% | 186 |
|
|
2025
Q1 | $338K | Hold |
1,615
| – | – | 0.03% | 165 |
|
|
2024
Q4 | $287K | Sell |
1,615
-56
| -3% | -$9.95K | 0.03% | 172 |
|
|
2024
Q3 | $330K | Hold |
1,671
| – | – | 0.03% | 172 |
|
|
2024
Q2 | $287K | Buy |
1,671
+64
| +4% | +$11K | 0.03% | 174 |
|
|
2024
Q1 | $293K | Buy |
1,607
+25
| +2% | +$4.55K | 0.03% | 172 |
|
|
2023
Q4 | $245K | Sell |
1,582
-82
| -5% | -$12.7K | 0.03% | 175 |
|
|
2023
Q3 | $248K | Sell |
1,664
-709
| -30% | -$106K | 0.03% | 159 |
|
|
2023
Q2 | $320K | Sell |
2,373
-44
| -2% | -$5.93K | 0.04% | 154 |
|
|
2023
Q1 | $385K | Buy |
2,417
+60
| +3% | +$9.56K | 0.05% | 152 |
|
|
2022
Q4 | $381K | Buy |
2,357
+314
| +15% | +$50.8K | 0.06% | 149 |
|
|
2022
Q3 | $274K | Sell |
2,043
-294
| -13% | -$39.4K | 0.05% | 159 |
|
|
2022
Q2 | $358K | Buy |
2,337
+261
| +13% | +$40K | 0.06% | 149 |
|
|
2022
Q1 | $336K | Buy |
2,076
+283
| +16% | +$45.8K | 0.04% | 161 |
|
|
2021
Q4 | $243K | Sell |
1,793
-131
| -7% | -$17.8K | 0.03% | 170 |
|
|
2021
Q3 | $208K | Sell |
1,924
-27
| -1% | -$2.92K | 0.03% | 174 |
|
|
2021
Q2 | $220K | Sell |
1,951
-567
| -23% | -$63.9K | 0.03% | 176 |
|
|
2021
Q1 | $272K | Buy |
+2,518
| New | +$272K | 0.04% | 158 |
|